In addition, a recent study using pancreatic patient samples revealed a mobilization of CD8+ T cells in juxtatumoral areas following CXCR4 inhibition and increased tumor cell killing when combined with PD-L1 inhibition [58]. Here, CXCR4 is linked to neoplasm.